A detailed history of Tucker Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tucker Asset Management LLC holds 5,794 shares of NVO stock, worth $625,809. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,794
Previous 3,495 65.78%
Holding current value
$625,809
Previous $449 Million 84.29%
% of portfolio
0.18%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $282,110 - $337,746
2,299 Added 65.78%
5,794 $827 Million
Q1 2024

Aug 09, 2024

BUY
$102.11 - $135.92 $64,125 - $85,357
628 Added 21.9%
3,495 $449 Million
Q4 2023

Mar 04, 2024

SELL
$87.78 - $105.45 $16,678 - $20,035
-190 Reduced 6.22%
2,867 $297 Million
Q3 2023

Dec 04, 2023

BUY
$90.94 - $199.54 $149,505 - $328,043
1,644 Added 116.35%
3,057 $278 Million
Q2 2023

Sep 08, 2023

SELL
$155.98 - $172.65 $1,715 - $1,899
-11 Reduced 0.77%
1,413 $229 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $87,079 - $104,714
658 Added 85.9%
1,424 $227 Million
Q4 2022

May 11, 2023

BUY
$102.55 - $135.33 $40,302 - $53,184
393 Added 35.34%
1,505 $203 Million
Q3 2022

May 11, 2023

BUY
$95.28 - $116.93 $33,824 - $41,510
355 Added 46.9%
1,112 $121 Million
Q2 2022

May 11, 2023

BUY
$103.24 - $121.81 $8,362 - $9,866
81 Added 11.98%
757 $84.4 Million
Q1 2022

May 11, 2023

BUY
$93.1 - $112.54 $71,314 - $86,205
766 New
766 $85.1 Million
Q4 2021

May 11, 2023

SELL
$95.88 - $117.08 $71,718 - $87,575
-748 Reduced 52.53%
676 $75.3 Million
Q3 2021

Aug 10, 2023

BUY
$84.42 - $106.62 $844 - $1,066
10 Added 1.61%
631 $69.5 Million
Q2 2021

Aug 10, 2023

BUY
$67.66 - $84.76 $6,021 - $7,543
89 Added 16.73%
621 $52 Million
Q1 2021

Aug 10, 2023

SELL
$67.06 - $75.82 $59,817 - $67,631
-892 Reduced 62.64%
532 $35.9 Million
Q4 2020

Jun 07, 2023

SELL
$63.89 - $73.8 $73,409 - $84,796
-1,149 Reduced 80.69%
275 $19.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.